Pfizer-ka ayaa ku habanaya balaayiin doolar nooc cusub oo kansarka ah Immunotherapy-ga Immunotherapy-ga Immunotherapy-ga Immunothapypypypypypypypay ee loo yaqaan 'Kansarka' PFIZER 'ee ku saabsan noocyada doolar ee ku saabsan kansarka cusub ee kansarka, oo oggolaanaya Isniinta si loo shatiraa nooc duawo ah - Bartilmaameedsiga dawada ee loo soo ifbaxay in ay tahay in loo soo bandhigo dadka dawooyinka ee oncology.
Garka dawooyinka wuxuu bixin doonaa shirkadda biotechnology-ga 3Sbio $ 1.5 bilyan kor u qaadistaXuquuqda ka baxsan Shiinaha ilaa terabiy-ga waxaa lagu daweeyaa SSGJ - 707. 3Sbio, oo sal ah Shyyg, Shiinaha, ayaa heli kara ilaa $ 4.8 bilyan oo dheeri ah mushahar dheeraad ah haddii daroogada ay ku dhufato yoolalka iyo kuwa iibka qaarkood ay tahay inay ugu dambeyntii gaaraan suuqa. Pfizer waxay sameyn doontaa $ 100 milyan oo maalgashi si caddaalad ah oo ah 3SBO marka loo eego xiritaanka heshiiska sidoo kale.
Heshiiska ayaa ka dhigaya Pfizer-ka wiishka ugu dambeeyay ee maandooriyaha sharad daroogada oo isla mar ahaantaana xirmooyinka borotiinka pd - 1 iyo vegfMarka loo eego iyada oo loo marayo taas oo ka caawiya burooyinka inay soo dhaafeyso nidaamka difaaca jirka oo ay koraan. Malgashiga maalgashiga ayaa imanaya ka dib hal daawo oo kale, Ivonessimar, Merck & Merck & Emytherapy The's Trustrothara Maxkamad 3aad oo waji ka ah kansarka sanbabada ee Shiinaha sanadkii hore. In ka badan dhowr shirkadood ayaa hadda horumarinaya iyaga. Inbadan waxay ku saleysan yihiin Shiinaha ama helay rajooyinkooda Ka yimid maandooriyaha Shiinaha, Muujinta Kororka waaxda Bootech halkaas.
"Waa iska cadahay in shirkad walba oo caalami ah] ay rabto PD - 1 / VEGF gacanta," ayuu Jeffels Fanstenst Falanqeeyaa Cui Cui oo ku saabsan macaamiisha Talaadada.
PD-yadaan PD - 1 / Vegf-ka waxay ka dhisan yihiin xiisaha maxaa yeelay waxaa laga yaabaa inay ku dhisaan Keytruda iyo daroogooyinka kale ee sidan oo kale, oo daweyn kara noocyada mutadawaalka ah oo ay ku kasbadaan balaayiin doolar iibka sanadlaha ah.
Si kastaba ha noqotee, su'aalaha ayaa weli ah, hase yeeshe. Natiijooyinka daraasadda ee ka soo baxay Ivonessimab maxkamadda ugu weyn ee Shiinaha ayaa soo jeedisay a Faa'iidada badbaadada dhexdhexaadka ah marka loo eego Keytruda, laakiin farqiga u dhexeeya wax aan waxtar lahayn oo lagu caddeeyo Ivonessimar ayaa ka fiican. Ma cadda in PD - 1 / Vegf-ka ay ka hortagaan daawooyinka caadiga ah ee noocyada kale ee burada, ama tijaabooyin caalami ah oo leh barkado badan oo kaqeybgaleyaal ah.
Pfizer waa eegaya oncology Si lagaaga caawiyo soo rogida wareegga saamiyada daba dheeraada iyo daqliga qaadashada tallaalka, iyo pd - Daroogooyinka vegf waxay qayb ka noqdeen dadaalkaas. Bishii Febraayo, waa Iskaashada Ivonessimab horsers Akeso iyo Shirka Shirweynaha Si aad wax uga barato dawadooda daawooyinka kansarka ee dhuumaha pfizer ee pfizer. Hadda Pvizer's waxay ku qabteen xuquuqda tartanka Ivonescmab ee hada ku jira tijaabooyin caafimaad oo ka dhacay Shiinaha kansarka sanbabada, kansarka macdanta ee metastat iyo burooyinka qaarkood.
Xusuusin:Dib loo soo celiyay biophadive. Haddii ay jiraan wax walaac ah oo xuquuq leh, fadlan la xiriir kooxda websaydhka ee ka saarista.
Waqtiga Post: 2025 - 05 - 30:39:49
